ATE183744T1 - (3r,4r)--g(d)?6-tetrahydrocannabinol-7- carbonsäuren - Google Patents
(3r,4r)--g(d)?6-tetrahydrocannabinol-7- carbonsäurenInfo
- Publication number
- ATE183744T1 ATE183744T1 AT93917149T AT93917149T ATE183744T1 AT E183744 T1 ATE183744 T1 AT E183744T1 AT 93917149 T AT93917149 T AT 93917149T AT 93917149 T AT93917149 T AT 93917149T AT E183744 T1 ATE183744 T1 AT E183744T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydrocannabinol
- carboxylic acids
- thc
- analgesic
- delta
- Prior art date
Links
- 239000002253 acid Substances 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
- Tires In General (AREA)
- Glass Compositions (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/913,096 US5338753A (en) | 1992-07-14 | 1992-07-14 | (3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE183744T1 true ATE183744T1 (de) | 1999-09-15 |
Family
ID=25432922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93917149T ATE183744T1 (de) | 1992-07-14 | 1993-07-13 | (3r,4r)--g(d)?6-tetrahydrocannabinol-7- carbonsäuren |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5338753A (de) |
| EP (1) | EP0650483B1 (de) |
| JP (1) | JP3278159B2 (de) |
| KR (1) | KR100289202B1 (de) |
| AT (1) | ATE183744T1 (de) |
| AU (1) | AU676845B2 (de) |
| CA (1) | CA2140368C (de) |
| DE (1) | DE69326149T2 (de) |
| DK (1) | DK0650483T3 (de) |
| ES (1) | ES2138626T3 (de) |
| GR (1) | GR3031966T3 (de) |
| WO (1) | WO1994001429A1 (de) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635530A (en) * | 1991-09-12 | 1997-06-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them |
| IL115245A (en) * | 1995-09-11 | 2002-12-01 | Yissum Res Dev Co | Tumor necrosis factor inhibiting pharmaceuticals |
| US6132762A (en) * | 1997-05-05 | 2000-10-17 | Cristobal; Walter | Transcutaneous application of marijuana |
| US6162829A (en) * | 1997-10-17 | 2000-12-19 | Atlantic Pharmaceuticals, Inc. | (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
| GB9807639D0 (en) | 1998-04-14 | 1998-06-10 | Kennedy Rheumatology Inst | Anti-inflammatory agents |
| US5847128A (en) * | 1998-05-29 | 1998-12-08 | Virginia Commonwealth University | Water soluble derivatives of cannabinoids |
| US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
| CN1377261A (zh) | 1999-03-22 | 2002-10-30 | 免疫力药品有限公司 | 治疗免疫疾病 |
| US6448288B1 (en) * | 2000-05-17 | 2002-09-10 | University Of Massachusetts | Cannabinoid drugs |
| AU2001296402A1 (en) * | 2000-09-28 | 2002-04-08 | Immugen Pharmaceuticals, Inc. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| US6541510B2 (en) * | 2000-09-28 | 2003-04-01 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
| US7507767B2 (en) * | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| US7067539B2 (en) * | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
| WO2003007876A2 (en) * | 2001-06-25 | 2003-01-30 | University Of Massachusetts | N-fatty acid-amino acid conjugates and therapeutic uses |
| CA2450073C (en) | 2001-07-25 | 2017-08-29 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| AR037352A1 (es) * | 2001-11-14 | 2004-11-03 | Schering Corp | Compuestos ligandos de los receptores de los cannabinoides, una composicion farmaceutica , y el uso de dichos compuestos para la manufactura de medicamentos |
| WO2003070277A1 (en) | 2002-02-19 | 2003-08-28 | Shionogi & Co., Ltd. | Antipruritics |
| WO2003080043A1 (en) * | 2002-03-18 | 2003-10-02 | Immugen Pharmaceuticals, Inc. | Topical formulations of resorcinols and cannibinoids and methods of use |
| EP1539693B9 (de) | 2002-06-19 | 2008-10-08 | Schering Corporation | Agonisten des cannabinoidrezeptors |
| DE60328033D1 (de) | 2002-11-25 | 2009-07-30 | Schering Corp | Cannabinoid-rezeptorliganden |
| WO2004058251A1 (en) * | 2002-12-19 | 2004-07-15 | University Of Massachusetts | Cannabinoid analogs as peroxisome proliferator activated nuclear receptor gamma activators |
| TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| US6916852B2 (en) * | 2003-05-12 | 2005-07-12 | University Of Tennessee Research Foundation | Method for regulation of microvascular tone |
| US20050070596A1 (en) * | 2003-05-12 | 2005-03-31 | David Baker | Methods for treatment of inflammatory diseases using CT-3 or analogs thereof |
| WO2005019811A2 (en) * | 2003-08-26 | 2005-03-03 | Blueshift Biotechnologies, Inc. | Time dependent fluorescence measurements |
| US20050264805A1 (en) * | 2004-02-09 | 2005-12-01 | Blueshift Biotechnologies, Inc. | Methods and apparatus for scanning small sample volumes |
| WO2006002133A1 (en) * | 2004-06-22 | 2006-01-05 | Schering Corporation | Cannabinoid receptor ligands |
| US7141378B2 (en) | 2004-07-02 | 2006-11-28 | Blueshift Biotechnologies, Inc. | Exploring fluorophore microenvironments |
| US7544714B2 (en) * | 2004-07-16 | 2009-06-09 | University Of Massachusetts | Lipid-amino acid conjugates and methods of use |
| WO2006065792A2 (en) * | 2004-12-13 | 2006-06-22 | Indevus Pharmaceuticals, Inc. | Treatment of interstitial cystitis using cannabinoid analogs |
| WO2006065793A2 (en) * | 2004-12-13 | 2006-06-22 | Indevus Pharmaceuticals, Inc. | TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR,10aR)-Δ8-TETRAHYDROCANNABINOL-11-OIC ACIDS |
| EP2671508B1 (de) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-Informatiksystem |
| TWI366460B (en) | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
| US20070037873A1 (en) * | 2005-08-08 | 2007-02-15 | Zurier Robert B | Airway remodeling treatments |
| EP2578561A1 (de) * | 2005-09-29 | 2013-04-10 | Albany Molecular Research, Inc. | Verfahren zur Herstellung von Cannavbidiolderivaten und deren Intermediaten |
| US20070093519A1 (en) * | 2005-10-20 | 2007-04-26 | Indevus Pharmaceuticals, Inc. | Anti-emetic uses of cannabinoid analogs |
| US20070099988A1 (en) * | 2005-10-31 | 2007-05-03 | Indevus Pharmaceuticals, Inc. | Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids |
| JP2010503710A (ja) | 2006-09-18 | 2010-02-04 | ラプトール ファーマシューティカル インコーポレイテッド | 受容体関連タンパク質(rap)結合体の投与による肝障害の処置 |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| KR20180114970A (ko) | 2009-05-06 | 2018-10-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| US9066910B2 (en) * | 2010-04-15 | 2015-06-30 | Steven Rosenblatt | Methods and compositions of cannabis extracts |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| KR20160002709A (ko) | 2013-02-12 | 2016-01-08 | 코버스 파마수티컬스, 아이엔씨. | 초고순도 테트라하이드로카나비놀-11-오익산 |
| US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
| US20170038184A1 (en) | 2015-08-06 | 2017-02-09 | Charles E. Ankner | Formulation delivery system |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US11202771B2 (en) | 2018-01-31 | 2021-12-21 | Treehouse Biotech, Inc. | Hemp powder |
| EP3864000A4 (de) | 2018-10-10 | 2022-08-10 | Treehouse Biosciences, Inc. | Synthese von cannabigerol |
| MX2022002183A (es) | 2019-08-22 | 2022-05-24 | Epm Group Inc | Composiciones de éster de ácido cannabinoide y sus usos. |
| WO2021072325A1 (en) * | 2019-10-11 | 2021-04-15 | Corbus Pharmaceuticals, Inc. | Compositions of ajulemic acid and uses thereof |
| US12029718B2 (en) | 2021-11-09 | 2024-07-09 | Cct Sciences, Llc | Process for production of essentially pure delta-9-tetrahydrocannabinol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4973603A (en) * | 1988-06-16 | 1990-11-27 | Sumner Burstein | Platelet activating factor antagonist and methods of use therefor |
| IL99468A (en) * | 1991-09-12 | 1997-09-30 | Yissum Res Dev Co | (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
-
1992
- 1992-07-14 US US07/913,096 patent/US5338753A/en not_active Expired - Lifetime
-
1993
- 1993-07-13 EP EP93917149A patent/EP0650483B1/de not_active Expired - Lifetime
- 1993-07-13 CA CA002140368A patent/CA2140368C/en not_active Expired - Fee Related
- 1993-07-13 WO PCT/US1993/006580 patent/WO1994001429A1/en not_active Ceased
- 1993-07-13 DK DK93917149T patent/DK0650483T3/da active
- 1993-07-13 KR KR1019950700133A patent/KR100289202B1/ko not_active Expired - Fee Related
- 1993-07-13 AT AT93917149T patent/ATE183744T1/de not_active IP Right Cessation
- 1993-07-13 JP JP50357494A patent/JP3278159B2/ja not_active Expired - Fee Related
- 1993-07-13 AU AU46759/93A patent/AU676845B2/en not_active Ceased
- 1993-07-13 DE DE69326149T patent/DE69326149T2/de not_active Expired - Fee Related
- 1993-07-13 ES ES93917149T patent/ES2138626T3/es not_active Expired - Lifetime
-
1999
- 1999-11-25 GR GR990403059T patent/GR3031966T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994001429A1 (en) | 1994-01-20 |
| EP0650483B1 (de) | 1999-08-25 |
| KR100289202B1 (ko) | 2001-05-02 |
| EP0650483A4 (en) | 1995-05-10 |
| ES2138626T3 (es) | 2000-01-16 |
| HK1010690A1 (en) | 1999-06-25 |
| KR950702549A (ko) | 1995-07-29 |
| AU4675993A (en) | 1994-01-31 |
| CA2140368A1 (en) | 1994-01-20 |
| AU676845B2 (en) | 1997-03-27 |
| EP0650483A1 (de) | 1995-05-03 |
| GR3031966T3 (en) | 2000-03-31 |
| DE69326149D1 (de) | 1999-09-30 |
| DK0650483T3 (da) | 2000-03-27 |
| JP3278159B2 (ja) | 2002-04-30 |
| US5338753A (en) | 1994-08-16 |
| JPH08500096A (ja) | 1996-01-09 |
| CA2140368C (en) | 2004-04-27 |
| DE69326149T2 (de) | 2000-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2138626T3 (es) | Acidos (3r,4r)-delta6-tetrahidrocannabinol-7-oicos. | |
| IT1256450B (it) | Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione | |
| MX9300630A (es) | Derivados de amidina, procedimiento para su preparacion y medicamentos que los contienen. | |
| CA2120942A1 (en) | Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino)phenyl-acetic acid and process for their preparation | |
| BG98902A (bg) | Имидазолови производни и тяхната употреба като инхибитори на цитокин | |
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| RU94040170A (ru) | Изохинолины | |
| ATE216590T1 (de) | Arzneimittelformulierungen für il-12 | |
| ATE211135T1 (de) | Aminocyclohexylester und ihre anwendung | |
| ES2130452T3 (es) | Derivados de ciclobutano utilizados como inhibidores de la escualeno-sintetasa y de la farnesiltransferasa proteica. | |
| BR9811099A (pt) | Inibidores de urocinase | |
| EP0957093A3 (de) | Retrovirusprotease Inhibitoren | |
| AU5736494A (en) | Cyclic sulfone containing retroviral protease inhibitors | |
| PT831826E (pt) | Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| BR9712141A (pt) | Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas. | |
| IT1276162B1 (it) | Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
| DE69434652D1 (de) | Antikonvulsive pseudofructopyranose sulfamate | |
| DK0727996T3 (da) | Fendazolformuleringer | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| BR9811954A (pt) | ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias | |
| DE69419954D1 (de) | Arzneimittel zur Behandlung von Hauterkrankungen | |
| ATE120369T1 (de) | Verwendung stabiler oxapenem-3-carbonsäuren zur herstellung beta-lactamase hemmender arzneimittel. | |
| DE59608611D1 (de) | Topische aciclovir-zubereitung | |
| ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |